ENTRY GUIDE - Informa Pharma Intelligence
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
T
O J
K A
Y P
O A
N
THURSDAY MAY 12 2022
PALACE HOTEL, TOKYO
ENTRY GUIDE
ENTRY DEADLIINE: FEBRUARY 4, 2022
ENTRY INQUIRIES:
Natalia Kay, Senior Events Manager • E: natalia.kay@informa.com
pharmaintelligence.informa.com/JapanAwards2022
Key date: Entry deadline: February 4 2022
WHY ENTER
The Informa Pharma Intelligence Awards recognize and reward
outstanding achievements and innovations made in Japanese pharma
and biotech, highlighting Japan’s integral role in the global life sciences C AT E G O R I E S
and healthcare market. These inaugural awards bring together leading
contributors to the global life sciences and healthcare market, to meet
and network, discover new opportunities, and reflect on life-changing
accomplishments made over the previous year. BEST CONTRACT RESEARCH
ORGANIZATION
Categories are diverse and wide-ranging, including Pharma Company of the Year, Best BEST NEW DRUG AWARD
New Drug Award and Best Contract Research Organization.
Brought to you by Informa Pharma Intelligence, the awards provide a unique and trusted BIOTECH COMPANY OF THE YEAR
platform to enable innovation, growth and commercial success for your organization.
• Honor your organization’s outstanding contribution to the pharma and biotech
industry. EXECUTIVE OF THE YEAR
• Showcase Japan’s pivotal role in driving innovation in the global healthcare market.
• Be recognized as one of Japan’s leading organizations, and a key contributor to the
global life sciences and healthcare market. LICENSING DEAL OF THE YEAR
• Reflect on the importance of your achievements, and share best practice with other
thought leaders in pharma and biotech.
PHARMA COMPANY OF THE YEAR
The Informa Pharma Intelligence Awards are free to enter. The closing date for entries
is February 4 2022, and the qualifying period for submissions is January 1 2021 to
December 31 2021. LIFETIME ACHIEVEMENT AWARD
The judging process will take place between February and March 2022. The finalists
will be contacted in March and the winners announced at the Awards ceremony on
May 12 2022.
B E ST CO N T RACT BEST NEW
RESEARCH D R U G AWA R D
O R G A N I Z AT I O N
The Best New Drug Award recognizes
excellence in pharmaceutical
This Award is to recognize CROs that development. In this category, the
provide full or specialist services to judges will be looking for the small-
their clients and which are based molecule, biological or vaccine
either in Japan or the Asia region product approved in Japan during the
(including Australia), but which offer qualifying period that represents the
services in Japan. best therapeutic advance in its area.
Judging will consider the quality of services and All recently launched new active substances are eligible
relationships built with clients. It will pay particular to enter as long as they were first licensed in Japan
attention to the innovative patient recruitment between January 1 - December 31 2021 (generic and
strategies the CRO has brought to the table. biosimilar products are not eligible).
To qualify, candidates must draw on their achievements Entrants must have played a role in the development of
in the 2021 calendar year. the nominated product, and all parties to joint ventures
should be disclosed in the application.
To enter this category, please answer the following:
To enter this category, please answer the following:
• What particular capabilities and strengths does the
CRO offer? • Brand and generic name, indication, company(ies)
involved in its development (if more than one
• How has the company delivered results that exceed company, please detail the relationship between the
sponsor expectations? parties)
• What innovations in patient recruitment strategy has • Date and market of approval and launch.
the CRO brought to its partner?
• Mechanism of action. How does this represent a step
• How has it improved its performance, for example, in forward?
its quality of data, timelines and transparency?
• Outline evidence for clinical activity. How does this
• What steps is the company taking towards translate into a meaningful therapeutic benefit for
streamlining data collection and reporting? patients and over other drugs?
• What is the potential market size of the candidate?
BIOTECH EXECUTIVE
C O M PA N Y O F OF THE YEAR
THE YEAR
Designed to acknowledge excellence
in leadership, the winner of this
This award honors outstanding award will be the executive who
achievements by biotech companies has exhibited exemplary leadership
over the qualifying 12-month period throughout the 12-month period of
of calendar 2021. This could be in calendar 2021. Also important to the
terms of moving the business from judges will be the executive’s career
an early stage to a more mature achievements, influence within the
company, signing a transformative industry and leadership qualities.
deal, taking its first or a major new
product towards the market, or raising Entrants must hold a C-suite executive position and be
significant new funds. employed by the company at the time of nomination.
To enter this category, please answer the following:
To enter this category, please provide the following • Entrant’s greatest achievements during the qualifying
information: year? What has been the direct consequence on
• The company’s most significant achievement during company performance?
the year. • How have these achievements strengthened the
• Accomplishments in terms of: bringing new products candidate’s influence within the industry?
closer to market; raising funds; significant licensing • Entrant’s greatest strengths as a leader? How did
or partnership deals; management not afraid of these have a bearing on their achievements this
making hard decisions; using proprietary science or year?
technologies for unmet medical needs; transition
from early stage to more mature company. • What specific previous accomplishments helped
with this success? For example, previous scientific or
management experience.
LICENSING PHARMA
DEAL OF THE C O M PA N Y O F
YEAR THE YEAR
(NON-ENTERABLE)
Deals considered here are those that
involve the licensing of a particular drug,
The Pharma Company of the
project or group of drugs/projects from
Year Award honors outstanding
one company to another for further
achievements by pharmaceutical
development and/ or marketing. Please
companies over the qualifying
note, it does not include more involved
12-month period of calendar 2021.
partnerships between companies to
explore particular therapeutic strategies.
This special award is chosen by Informa’s senior editorial
team, based on a variety of key metrics as below:
The judges will look at all aspects from monetary and
• Financial performance compared with the same
strategic value to the benefits they give to both sides.
period in previous fiscal year
To qualify, licensing deals must have been closed during
calendar year 2021. • Strategic advances, looking at most significant
achievements over the year
To enter this category, please provide the following
• Progress in emerging markets
information:
• New product launches including line-extensions and
• Outline the structure of the deal, giving the names
formulations
of the parties involved, the drug candidate(s)
concerned, and what rights it covers. • Advances in the drug pipeline, including major
clinical trial reports
• Monetary value of the deal in up-front and milestone
payments.
• Geographic spread of the deal and does it allow any
party to enter new markets?
• Strategic value of the licensed product to the
licensee’s business.
• Please explain how the licensed product was the best
possible candidate to complement the rest of the
licensee’s pipeline or particular disease franchise.
LIFETIME ACHIEVEMENT AWA R D The winner of this Award will be an exceptional individual with a consistent history of service, above and beyond the call of duty, throughout their distinguished career in the biotech or pharmaceutical arena, primarily within industry. We welcome nominees for consideration for this Award but the decision lies with Informa’s senior editorial team. The winner may be retired or semi-retired but will still be active in the industry in some capacity. Any nomination should outline in no more than 1,500 words what the nominee has accomplished during his or her career and say why they are worthy of this Award. Guidance on your nomination: • An exceptional individual with a consistent history of service throughout their career. • Distinguished career in the biotech or pharmaceutical arena, primarily within industry. • Participation in broader influencing roles such as associations and other groups. • Active role in bringing about positive change. • Retired or semi-retired but still active in the industry in some capacity.
J U D G I N G A N D T H E PA N E L
The Informa Pharma Intelligence Awards will be judged by a panel of industry
experts within academia and business, with extensive experience in Japan.
Each of the judges brings a wealth of specialist knowledge, experience and
expertise, carefully selected for their credibility and objectivity.
The Judging Panel is independent and considers entries objectively; each category
entry is reviewed by at least three, individual judges. The judges score each entry
against the listed criteria for the category, and the scores are marked out of ten for
each category answer. The Awards team collate the scores to determine which entries
are included in the shortlist, and the ultimate winner.
The chair of the Judging Panel reserves the right to cast any deciding vote, should
the need arise. The judges’ decision is final - neither the organizers, nor the Judging
Panel, will enter into any correspondence about the results. Details of the winners
are strictly embargoed until the Awards night, but details of all the shortlisted entries
will be listed on pharmaintelligence.informa.com/JapanAwards2022
Steve Engen
Dr Yujiro Maeda
CEO, Renexes LLC, ex-President,
University of Tokyo Hospital/
Mundipharma Japan and Solasia
Japan Biodesign/Premo Partners
Pharma
Mitsuru Miyata
Dr Shoichiro Hamano
CEO, Miyata Institute of Technologies/
CEO, Hamano International
President, Healthcare Innovation
Thomas Jonsson Fumiyoshi Sakai
Managing Director Credit Suisse Securities, Senior
Zinagi Consulting Analyst/Director
Shingo Kano Dr Noboru Yamamoto
Professor, University of Tokyo/ Deputy director of the National
Graduate School of Frontier Cancer Center Hospital, director,
Sciences Department of Experimental
Therapeutics and Clinical
Research Support Office
Koji Kawakami
Professor, Graduate School of
Medicine, Kyoto University
HOW TO ENTER
Entrant companies may be based either in Japan or overseas but must have
business operations in Japan. However, there are detailed requirements for
each category. If you have any questions, please feel free to contact us.
Entries are free of charge.
1 2 3
Select your category. Complete the downloadable entry form, Email your completed PDF entry form to
explaining in 1,500 words or less, why your the Awards team. You will then receive a
organization should be recognized for its confirmation email from one of the team.
performance. Please refer to the category criteria
as a guide.
Entry deadline: February 4 2022 Entry and general inquiries
pharmaintelligence.informa.com/JapanAwards2022 natalia.kay@informa.com
OUR PORTFOLIO OF SERVICES
Trusted by over 3,000 of the world’s leading pharmaceutical companies, At Pharma Intelligence, global teams of subject area
CROs, medtech and biotech organizations, and healthcare service providers, experts follow and analyze key diseases, clinical trials,
the Pharma Intelligence suite of intelligence solutions delivers vital, drug approvals and R&D activities as part of the breadth
accurate, and timely intelligence about the drug development pipeline to and depth of data available to customers.
pharmaceutical and biomedical decision makers around the world.
CROSS
CLINICAL EXCELLENCE COMMERCIAL EXCELLENCE REGULATORY EXCELLENCE PORTFOLIO
Leverage the portfolio
via a single entry point
and create your view of
the complete pharma
landscape.
Track global R&D pipeline The industry’s gold Real-time analysis of Probability of success The most widely used Global pharma regulatory,
- from bench to patient standard for clinical trials major market-moving tool allows you to platform for clinical trial compliance and policy Integrate the data you
- with most trusted drug intelligence, made by events, deals and analyze drugs’ clinical & disclosure management. updates and insights need into your internal
development database experts for experts company info for the regulatory success Streamlines and simplifies systems to gain new
biopharma industry from registration to results insights and workflows
NEWS & INSIGHT
Select the right sites Feasibility scenarios can In-depth market Business-critical market
and investigators with be instantly modelled, assessments, detailed & company insight for
Ready-made and custom
experience and patients optimized, compared, research reports and commercial decision-
analytic solutions that
in proximity (based on and shared with explain- expert analysis of the makers in the pharma
answer your business
medical claims) ability and transparency biopharma industry industry What key players in the Unrivalled coverage, news questions
biopharma, medtech, and and analysis of the global
diagnostics industries are generics, biosimilars and
thinking and what your value-added medicines
competitors are doing industries
Accelerate clinical trial Recruit patients through Global news, insight Understand medical
timelines by gathering an industry-first collective and analysis of medical device market trends, Find clarity in an ever-
input from HCPs/patients, of over 70 recruitment technologies track key milestones evolving landscape from
raising awareness of partners in a pay-for- and identify partnership big picture to the smallest
trials, and recruiting performance model opportunities. Regulatory, legal, legislative and commercial news details; delivered in the
investigators and referral and insight for the OTC, dietary supplements and format you require
centers cosmetic markets
FAQ s
Q. How do I enter? Q. How will I know whether my entry has been
A. Please take your time to read the entry guidelines received?
and category criteria and decide which category is A. Once your entry has been submitted, your
most applicable to your organization. organization will be acknowledged by an email.
Download a PDF entry form from Our Awards team will also be in touch after the
pharmaintelligence.informa.com/JapanAwards2022. entry deadline. If you have any questions or
Answer the questions and criteria relevant to your concerns, please contact Natalia Kay at
chosen category. Once completed, please email natalia.kay@informa.com
your completed PDF entry form to the Awards
team before February 4 2022.
Q. How will I know if my submission has been
successful?
Q. How much does it cost to enter? A. Following the judging process, all organizations
A. Informa Pharma Intelligence Awards are free to will be notified by email. Finalists will be
enter. announced on the Informa Pharma
Intelligence Awards website:
pharmaintelligence.informa.com/JapanAwards2022
Q. When is the entry deadline?
A. Entries are accepted until February 4 2022.
Q. What happens if I win?
A. All winners will be announced at the Awards
Q. I am not sure which category is applicable? ceremony. Each winner will receive a trophy
and certificate of recognition, as well as a press
A. If you are unsure which category is most suitable
release.
for your organization, please contact Natalia
Kay at natalia.kay@informa.com for further
assistance.
Q. How do I get tickets for the event?
A. Please contact Christopher Keeling on
Q. Is it possible to enter the same submission +44 (0) 7917 647 859 or
into more than one category? christopher.keeling@informa.com
for further information.
A. Where appropriate, we do encourage
organizations to enter more than one category.
Please ensure you review the category criteria and
tailor your entry accordingly. Q. What other ways can my organization be
involved with the Awards?
A. There are a number of sponsorship opportunities
Q. I am a sponsor of the Awards, am I still able available. Please contact Christopher Keeling on
to enter? +44 (0) 7917 647 859 or
christopher.keeling@informa.com
A. Sponsors are very welcome to enter the Awards,
for further information.
however, they are unable to enter the category
they are sponsoring.THE RULES CONFIDENTIALITY
• All entries must be written in Japanese or • Informa, organizer of the Informa Pharma
English. Intelligence Awards, recognizes and respects
the sensitive nature of the information
• All entries must be submitted by a PDF entry
submitted in the entries. We ensure that this
form, which can be downloaded on
recognition is shared by our Judging Panel
pharmaintelligence.informa.com/
and therefore require each judge to sign a
JapanAwards2022
confidentiality agreement before they are
• Once your PDF entry form has been completed, appointed.
it needs to be emailed to the Awards team.
• Entries are not disclosed or discussed outside
• Limit your entry to 1,500 words. the judging process.
• All entries must be accompanied by a 250-word • Once an entry is shortlisted, extracts from
summary of the entry as you would like it to the entry summary only will be sourced for
appear on all publicity material (this is in addition inclusion in the Awards ceremony and any
to the 1,500-word entry). Please do not include subsequent editorial coverage.
confidential material in your 250-word summary.
• Please ensure your entry summary contains
We reserve the right to amend your summary if
no confidential or sensitive information. The
needed.
Judging Panel for each Award is selected to
• All entries must be based on activities avoid any conflict of interest.
undertaken between January 1 2021 to
December 31 2021.
• Your organization may enter more than one
category, provided that each entry has been
specifically written to address the relevant
criteria and is accompanied by a separate
summary.ENTRY AND GENERAL SPONSORSHIP AND
INQUIRIES: ATTENDANCE INQUIRIES:
Natalia Kay Christopher Keeling
Senior Events Manager Sponsorship and Sales Manager
E: natalia.kay@informa.com E: christopher.keeling@informa.com
pharmaintelligence.informa.com/JapanAwards2022You can also read
